Heart failure and SGLT2 inhibition: understanding the mechanism for potential benefit
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Diabetes & Heart Failure: Evaluating novel strategies to address outcomesSGLT2 inhibition and cardiovascular outcomes: lessons from recent clinical trials
David Fitchett, MD
- Diabetes & Heart Failure: Evaluating novel strategies to address outcomesCurrent treatment of Diabetes in Heart Failure
Adriaan Voors, MD
